Tradition Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,199
Closed -$4K 1040
2023
Q4
$4K Hold
7,199
﹤0.01% 1196
2023
Q3
$4K Buy
7,199
+1,800
+33% +$1.93K ﹤0.01% 1252
2023
Q2
$7K Hold
5,399
﹤0.01% 1131
2023
Q1
$10K Hold
5,399
﹤0.01% 1009
2022
Q4
$17K Hold
5,399
﹤0.01% 786
2022
Q3
$26K Hold
5,399
﹤0.01% 695
2022
Q2
$22K Hold
5,399
﹤0.01% 631
2022
Q1
$31K Hold
5,399
﹤0.01% 623
2021
Q4
$40K Hold
5,399
0.01% 587
2021
Q3
$49K Hold
5,399
0.01% 511
2021
Q2
$65K Hold
5,399
0.01% 475
2021
Q1
$68K Hold
5,399
0.01% 380
2020
Q4
$84K Buy
+5,399
New +$63.2K 0.02% 319

Other funds holding SGMO

Tradition Wealth Management's SGMO Position: Q1 2024 in Review

Tradition Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2024, closing a stake of 7,199 shares — an estimated $4K sold.

Tradition Wealth Management first reported a position in SGMO in Q4 2020 and held it in 13 quarters. The position peaked at $84K in Q4 2020. 131 funds tracked by Wall St. Rank hold SGMO as of Q1 2024.

  • Tradition Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2024 after selling out during the quarter.
  • Tradition Wealth Management sold 7,199 SANGAMO THERAPEUTICS INC shares in Q1 2024, an estimated $4K.
  • Tradition Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 13 quarters.
  • Tradition Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $84K in Q4 2020.
  • 131 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2024.

Based on Tradition Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.